Skip to content
中文产业新闻精选评分66Chinese source

艾力斯回应伏美替尼FURVENT三期失败:称化疗组评估差异大、专家认可疗效预期

艾力斯回应海外Ⅲ期临床研究失败!

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.